Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117432) titled 'Assessment of immunotherapy associated drug related problems in cancer patients' on Sept. 10.
Study Type: Observational
Study Design:
Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Manikant Basavaraj karadesai
Condition:
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Intervention:
Intervention1: Nil: Nil
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 21-09-2026
Target Sample Size: 108
Countries of Recruitment:
India
To...